Results 261 to 270 of about 368,924 (355)

Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study

International Journal of Cancer, EarlyView.
What's New? This study evaluated patient characteristics and treatment strategies in stages II and III HR+/HER2− breast cancer. Neoadjuvant systemic therapy frequently facilitated breast‐conserving procedures and less invasive axillary surgery. Approximately half of the patients undergoing primary surgery received a mastectomy, and all with positive ...
Layla Andour, Judith R. Kroep, Hein Putter, Rob A. E. M. Tollenaar, Wilma E. Mesker, Marieke E. Straver   +5 more
wiley   +1 more source

NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS). [PDF]

Histopathology
Christgen M, Bartels S, Kreipe H.
europepmc   +1 more source

Tissue testing after breast reduction [PDF]

, 2009
Gøtzsche, PC, Keshtgar, M, Nathanson, V, Treasure, T   +3 more
core  

Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison

International Journal of Cancer, EarlyView.
What's New? Marked differences in esophageal and gastric cancer survival rates exist between the Netherlands and Belgium, for reasons that remain unclear. In this study, the authors in‐vestigated these differences and attempted to identify contributing factors.
Benthe H. Doeve, Steven C. Kuijper, Geert Silversmit, Lien van Walle, Philippe Nafteux, Camiel Rosman, Pauline A. J. Vissers, Paul Jeene, Laurens V. Beerepoot, Sarah Derks, Amine Karimi, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven   +13 more
wiley   +1 more source

Quality of Life Among Patients With Ductal Carcinoma In Situ.

JAMA Netw Open
Dunsmore VJ, Snyder BS, Gareen IF, Lehman CD, Khan SA, Romanoff J, Gatsonis C, Corsetti RL, Rahbar H, Spell DW, Han LK, Bumberry JR, Miller KD, Sparano JA, Comstock C, Park E, Wagner LI, Carlos RC.   +17 more
europepmc   +1 more source

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status. [PDF]

Int J Cancer
Schmitz RSJM, van den Belt-Dusebout AW, van Seijen M, Verschuur EAJ, van Duijnhoven FH, Schaapveld M, Lips EH, Wesseling J, Schmidt MK.   +8 more
europepmc   +1 more source

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

International Journal of Cancer, EarlyView.
What's New? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan, Elizabeth T. Bartom, Carolina H. Chung, Xingyu Guo, Kyli Berkley, Seyyedmohsen Hosseinibarkooie, Zahra Assadi, Shao Huan Samuel Weng, Raymond Moellering, Oukseub Lee, Ruohui Chen, Wonhwa Cho, Sriram Chandrasekaran, Susan E. Clare, Seema A. Khan   +14 more
wiley   +1 more source

Ductal Carcinoma In Situ of the Breast: An Analysis of 12 Years of Experience From a Tertiary Center. [PDF]

Cureus
Tepetam H, Hanilce MM, Dursun CU, Gedik D, Karabulut Gul S.   +4 more
europepmc   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

International Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu, Jia Wu, Jianjun Zhang, Robert Taylor Ripley, Christopher I. Amos, Chao Cheng   +9 more
wiley   +1 more source

Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ. [PDF]

Diagnostics (Basel)
Kim NI, Park MH, Lee JS.
europepmc   +1 more source